期刊文献+
共找到26篇文章
< 1 2 >
每页显示 20 50 100
Mechanisms of cancer metastasis to the bone 被引量:50
1
作者 Claire B. POLLOCK Kathleen KELLY 《Cell Research》 SCIE CAS CSCD 2005年第1期57-62,共6页
Some of the most common human cancers, including breast cancer, prostate cancer, and lung cancer, metastasize with avidity to bone. What is the basis for their preferential growth within the bone microenvironment? Bid... Some of the most common human cancers, including breast cancer, prostate cancer, and lung cancer, metastasize with avidity to bone. What is the basis for their preferential growth within the bone microenvironment? Bidirectional interactions between tumor cells and cells that make up bone result in a selective advantage for tumor growth and can lead to bone destruction or new bone matrix deposition. This review discusses our current understanding of the molecu- lar components and mechanisms that are responsible for those interactions. 展开更多
关键词 骨转移 肿瘤转移 软骨性转移 溶骨性转移 交互作用
下载PDF
Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer 被引量:9
2
作者 Min Jung Jo Ji Yeon Park +8 位作者 Joon Seon Song Myeong-Cherl Kook Keun Won Ryu Soo-Jeong Cho Jun Ho Lee Byung-Ho Nam Eun Kyung Hong Il Ju Choi Young-Woo Kim 《World Journal of Gastroenterology》 SCIE CAS 2015年第2期667-674,共8页
AIM: To evaluate the biopathologic features and clinical significance of nodal micrometastasis(MI) in early gastric cancer(EGC).METHODS: Among 1022 EGC patients who underwent gastrectomy with lymphadenectomy of D1 + ... AIM: To evaluate the biopathologic features and clinical significance of nodal micrometastasis(MI) in early gastric cancer(EGC).METHODS: Among 1022 EGC patients who underwent gastrectomy with lymphadenectomy of D1 + β or more from March 2001 to December 2005 at the Korean National Cancer Center, available nodal metastasis was found in 90 p T1N1 patients. Nodal metastasis was confirmed by immunohistochemistry(IHC) with cytokeratin and patients were classified into MI and macrometastasis(MA) groups based on the main tumor burden according to the 6th International Union Against Cancer/American Joint Committee on Cancer staging system; the main tumor burden with a diameter of greater than 0.2 mm but no greater than 2 mm as MI, and greater than 2 mm as MA of the representative metastatic node. Proliferative and apoptotic activities of the primary tumor and the nodal metastasis were measured by IHC with Ki-67 and terminal deoxynucleotidyl transferase d UTP nick end labeling, respectively. Biopathologic and clinical features of the patients were analyzed and compared between MI and MA groups. Patients with recurrence were compared with those without recurrence to identify risk factors for recurrence.RESULTS: Thirty-seven patients showed MI and the other 53 patients revealed MA in the lymph node; the incidence of patients with MI and MA was 41.1% and 58.9%. The main tumor burden was 0.9 and 4.6 mm in the representative metastatic node, respectively. Japanese N2 stations were more frequently involved in MA group(20.9%) than in MI group(10.3%) butthe difference was not statistically different(P = 0.338). Proliferative and apoptotic activities of MI were decreased than those of MA(26.7% vs 40.5%, P = 0.004 and 1.0% vs 3.0%, P < 0.001, respectively). However, nodal MI in the current study showed a relatively high proliferative activity and an equivalent apoptotic activity compared to other cancers in the previously published studies. Recurrence was observed in 6 patients during the mean follow up period of 87.6 ± 26.2 mo. The recurrence was significantly associated with the presence of MA(P = 0.041) and lymphovascular invasion of the primary tumor(P = 0.032).CONCLUSION: Lymphadenectomy of D1 + β or more might be necessary in patients with MI in sentinel node to prevent recurrence by clearing MI involving Japanese N2 station. 展开更多
关键词 EARLY GASTRIC cancer SENTINEL NODE BIOPSY Lymphade
下载PDF
Feasible economic strategies to improve screening compliance for colorectal cancer in Korea 被引量:3
3
作者 Sang Min Park Young Ho Yun Soonman Kwon 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第11期1587-1593,共7页
AIM: While colorectal cancer (CRC) is an ideal target for population screening, physician and patient attitudes contribute to low levels of screening uptake. This study was carried out to find feasible economic strate... AIM: While colorectal cancer (CRC) is an ideal target for population screening, physician and patient attitudes contribute to low levels of screening uptake. This study was carried out to find feasible economic strategies to improve the CRC screening compliance in Korea.METHODS: The natural history of a simulated cohort of 50-year-old Korean in the general population was modeled with CRC screening until the age of 80 years. Cases of positive results were worked up with colonoscopy. After polypectomy, colonoscopy was repeated every 3 years.Baseline screening compliance without insurance coverage by the national health insurance (NHI) was assumed to be 30% . If NHI covered the CRC screening or the reimbursement of screening to physicians increased, the compliance was assumed to increase. We evaluated 16different CRC screening strategies based on Markov model.RESULTS: When the NHI did not cover the screening and compliance was 30%, non-dominated strategies were colonoscopy every 5 years (COL5) and colonoscopy every 3 years (COL3). In all scenarios of various compliance rates with raised coverage of the NHI and increased reimbursement of colonoscopy, COL10, COL5 and COL3were non-dominated strategies, and COL10 had lower or minimal incremental medical cost and financial burden on the NHI than the strategy of no screening. These results were stable with sensitivity analyses.CONCLUSION: Economic strategies for promoting screening compliance can be accompanied by expanding insurance coverage by the NHI and by increasing reimbursement for CRC screening to providers. COL10was a cost-effective and cost saving screening strategy for CRC in Korea. 展开更多
关键词 结肠癌 直肠癌 经济学分析 医疗保险 韩国 医疗费用
下载PDF
Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers 被引量:2
4
作者 You-Kyung Jeon Sung-Hee Kim +4 位作者 Seung-Ho Choi Kyung-Hee Kim Byong-Chul Yoo Ja-Lok Ku Jae-Gahb Park 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第25期3153-3160,共8页
AIM: To understand CD133 promoter hypermethyl-ation and expression in 32 colorectal cancer cell lines. METHODS: Nucleic acid was isolated from 32 colorectal cancer cell lines and CD133 expression levels were measured ... AIM: To understand CD133 promoter hypermethyl-ation and expression in 32 colorectal cancer cell lines. METHODS: Nucleic acid was isolated from 32 colorectal cancer cell lines and CD133 expression levels were measured by reverse transcription-polymerase chain reaction (RT-PCR) and real-time PCR. Promoter methylation status of the CD133 gene was analyzed with a methylation-specific PCR after sodium-bisulfi te modification and by clonal sequencing analysis. The correlation between expression and promoter methylation of CD133 gene was confirmed with treatment of 5-aza-2’-deoxycytidine. RESULTS: We measured CD133 expression levels in 32 colorectal cancer cell lines. RT-PCR analysis showed undetectable or low levels of CD133 expression in 34.4%of cell lines. To verify the relation between CD133 expression and methylation status of the CD133 gene promoter in colorectal carcinogenesis, CD133 gene promoter hypermethylation was analyzed in 32 cancer cell lines. Promoter hypermethylation was detected in 13 (40.6%) of the cell lines using methylation specificPCR and confirmed by bisulfite sequencing analysis. Treatment of 11 of the cell lines with the demethylation agent 5-aza-2’-deoxycytidine recovered CD133 expression in most of them. CONCLUSION: Transcriptional repression of CD133 is caused by promoter hypermethylation of the CD133 CpG islands in some of colorectal cancer cell lines. The study may contribute to the understanding of the role of CD133 inactivation in the progression of colorectal cancers. 展开更多
关键词 CD133 PROMOTER HYPERMETHYLATION Colorectal cancer Sodium bisulfite modification
下载PDF
Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer 被引量:2
5
作者 Hong Man Yoon Young-Woo Kim +4 位作者 Byung Ho Nam Daniel Reim Bang Wool Eom Ji Yeon Park Keun Won Ryu 《World Journal of Gastroenterology》 SCIE CAS 2014年第7期1852-1857,共6页
AIM:To determine whether the application of postoperative intravenous(IV)-iron for acute isovolemic anemia after gastrectomy for cancer may be effective.METHODS:Among 2078 gastric cancer patients who underwent surgery... AIM:To determine whether the application of postoperative intravenous(IV)-iron for acute isovolemic anemia after gastrectomy for cancer may be effective.METHODS:Among 2078 gastric cancer patients who underwent surgery between February 2007 and August2009 at the National Cancer Center Korea,368 patients developed post-operative anemia[hemoglobin-(Hb)-level<9 g/dL]within the first postoperative week.Patients requiring transfusions were excluded.IV-iron was administered to 63 patients(iron group).Sixty patients were observed without treatment(observation group).The clinical outcomes of the groups were compared concerning clinicopathologic data,morbidity,and changes in Hb levels using Fisher’s exact test,Student’s t-test and the Z-test.RESULTS:The initial Hb level was higher in the iron group than in the observation group(7.3±1.0 g/dL vs8.4±0.5 g/dL,P<0.001).The slope of the changes in the Hb level was significantly higher in the iron group than in the observation group(0.648±0.054 vs 0.349±0.038,P<0.001).The Hb level 1 and 3 mo postoperatively increased from 10.7±1.3 to 11.9±1.3g/dL in the iron group(P=0.033)and from 10.1±1.0to 10.8±1.4 g/dL in the observation group(P<0.001).The postoperative hospital stay was significantly longer in the iron group than in the observation group(10.5±6.8 d vs 7.6±5.5 d,P=0.011).There were no significant differences in the major and surgical complications between the groups(6.3%vs 13.3%,P=0.192;9.5%vs 3.3%,P=0.164).CONCLUSION:IV-iron supplementation may be an effective treatment for post-operative isovolemic postgastrectomy anemia and may be a better alternative than observation. 展开更多
关键词 INTRAVENOUS iron OBSERVATION Gastric CANCER ACUTE
下载PDF
Prostate cancer and metastasis initiating stem cells 被引量:2
6
作者 Kathleen Kelly Juan Juan Yin 《Cell Research》 SCIE CAS CSCD 2008年第5期528-537,共10页
雄激素倔强的前列腺癌症转移是主要临床的挑战。对待前列腺癌症转移的基于机制的途径要求开始转移的房间的发展起源的理解。象关于区分的显型和雄激素独立的粘性那样的前列腺癌症转移的性质与前列腺的转变一致上皮的祖先或干细胞导致转... 雄激素倔强的前列腺癌症转移是主要临床的挑战。对待前列腺癌症转移的基于机制的途径要求开始转移的房间的发展起源的理解。象关于区分的显型和雄激素独立的粘性那样的前列腺癌症转移的性质与前列腺的转变一致上皮的祖先或干细胞导致转移。这评论在探讨正常前列腺茎或祖先细胞和他们的转变对应物的鉴定和性质的当前的证据和概念之上集中。 展开更多
关键词 前列腺癌 肿瘤转移 干细胞 男性激素
下载PDF
High morbidity in myocardial infarction and heart failure patients after gastric cancer surgery 被引量:2
7
作者 Sang-Ho Jeong Young-Woo Kim +7 位作者 Wansik Yu Sang Ho Lee Young Kyu Park Seong-Heum Park In Ho Jeong Sang Eok Lee Yongwhi Park Young-Joon Lee 《World Journal of Gastroenterology》 SCIE CAS 2015年第21期6631-6638,共8页
AIM:To evaluate to morbidity and mortality differences between 4 underlying heart diseases,myocardial infarction(MI),angina pectoris(Angina),heart failure(HF),and atrial fibrillation(AF),after radical surgery for gast... AIM:To evaluate to morbidity and mortality differences between 4 underlying heart diseases,myocardial infarction(MI),angina pectoris(Angina),heart failure(HF),and atrial fibrillation(AF),after radical surgery for gastric cancer.METHODS:We retrospectively collected data from 221 patients of a total of 15167 patients who underwent radical gastrectomy and were preoperatively diagnosed with a history of Angina,MI,HF,or AF in 8 hospitals.RESULTS:We find that the total morbidity rate is significantly higher in the MI group(44%) than the Angina(15.7%),AF(18.8%),and HF(23.1%) groups(P < 0.01).Moreover,we note that the risk for postoperative cardiac problems is higher in patients with a history of HF(23.1%) than patients with a historyof Angina(2.2%),AF(4.3%),or MI(6%; P = 0.01).The HF and MI groups each have 1 case of cardiogenic mortality.CONCLUSION:We conclude that MI patients have a higher risk of morbidity,and HF patients have a higher risk of postoperative cardiac problems than Angina or AF. 展开更多
关键词 STOMACH NEOPLASM COMORBIDITY MORBIDITY HEART disease HEART failure
下载PDF
鼻咽癌组织中BMI1和ERK3的表达及其临床意义
8
作者 李民英 闫新玉 +7 位作者 王婷 曾玉梅 张晶晶 郑斯明 周嘉雄 李娅妮 查雅文 文磊 《广东医学》 CAS 2023年第8期1025-1031,共7页
目的探讨鼻咽癌(NPC)组织中BMI1和ERK3的表达、两者的相关性及其在NPC侵袭转移中的作用。方法检索并下载GEO数据库中NPC测序基因集GSE103611和GSE34573,分析BMI1和ERK3基因表达数据。采用免疫组化MaxVision法检测51例NPC患者组织和18例... 目的探讨鼻咽癌(NPC)组织中BMI1和ERK3的表达、两者的相关性及其在NPC侵袭转移中的作用。方法检索并下载GEO数据库中NPC测序基因集GSE103611和GSE34573,分析BMI1和ERK3基因表达数据。采用免疫组化MaxVision法检测51例NPC患者组织和18例慢性鼻咽炎组织中BMI1和ERK3的表达情况,结合随访资料分析以上指标的临床意义。结果BMI1在NPC组织和慢性鼻咽炎组织中的阳性率分别是56.9%和22.2%,ERK3在NPC组织和慢性鼻咽炎组织中的阳性率分别是52.9%和11.1%。BMI1和ERK3在NPC组织中的阳性率均高于慢性鼻咽炎组织(P<0.05),尤其在NPC的N2~3组中两者呈显著高表达。BMI1与ERK3的表达呈正相关(r_(s)=0.345,P<0.05)。同时在NPC组织中BMI1和ERK3的表达与T分期、N分期以及总分期有关(P<0.05),与患者性别、初诊血清EBV DNA拷贝数无关(P>0.05)。结论BMI1/ERK3通路可在NPC的侵袭转移中发挥一定的作用。 展开更多
关键词 鼻咽癌 BMI1 ERK3 免疫组织化学 转移/侵袭
下载PDF
IC联合CCRT对局部晚期宫颈癌的疗效及安全性分析
9
作者 兰堃田 陈姣红 《保健医学研究与实践》 2023年第8期43-46,共4页
目的探讨诱导化疗(IC)联合同步放化疗(CCRT)治疗局部晚期宫颈癌(LACC)的疗效及安全性,以期为临床治疗提供参考。方法选取2019年5月—2021年5月三门峡市中心医院肿瘤分院收治的100例LACC患者作为研究对象,采用随机数字表法将患者分为对照... 目的探讨诱导化疗(IC)联合同步放化疗(CCRT)治疗局部晚期宫颈癌(LACC)的疗效及安全性,以期为临床治疗提供参考。方法选取2019年5月—2021年5月三门峡市中心医院肿瘤分院收治的100例LACC患者作为研究对象,采用随机数字表法将患者分为对照组(50例)与研究组(50例)。对照组患者接受CCRT治疗,研究组患者在CCRT治疗前先行21 d的IC治疗。比较2组患者的客观缓解率(ORR);比较2组患者治疗前后血清糖类抗原125(CA125)、鳞状细胞癌抗原(SCCA)、癌胚抗原(CEA)水平;比较2组患者毒副反应发生率。结果研究组患者ORR高于对照组,差异有统计学意义(P<0.05)。治疗前,2组患者CA125、SCCA、CEA水平比较,差异无统计学意义(P>0.05)。治疗后,2组患者CA125、SCCA、CEA水平均低于本组治疗前,且研究组低于对照组,差异均有统计学意义(P<0.05)。2组患者毒副反应发生情况比较,差异无统计学意义(P>0.05)。结论IC联合CCRT治疗LACC的疗效确切,可有效改善患者血清肿瘤标志物水平,减小患者肿瘤直径,提高患者ORR,安全性高,且治疗方案易于实施,具有临床推广应用价值。 展开更多
关键词 局部晚期宫颈癌 诱导化疗 安全性 同步放化疗 血清肿瘤标志物
下载PDF
放疗、吉西他滨联合免疫检查点抑制剂的三重疗法对三阴性乳腺癌肿瘤微环境的作用机制
10
作者 吴苗苗 房坤 《中国医药导报》 CAS 2023年第33期28-33,共6页
目的探讨放疗、吉西他滨(Gem)联合免疫检查点抑制剂的三重疗法对三阴性乳腺癌肿瘤微环境的影响,并揭示其可能的发生机制。方法选取29只雌性5周龄体重18~20 g的SPF级BALB/c小鼠,实验第1天在其左腹部皮下注射约1×106个4T1细胞,建立... 目的探讨放疗、吉西他滨(Gem)联合免疫检查点抑制剂的三重疗法对三阴性乳腺癌肿瘤微环境的影响,并揭示其可能的发生机制。方法选取29只雌性5周龄体重18~20 g的SPF级BALB/c小鼠,实验第1天在其左腹部皮下注射约1×106个4T1细胞,建立三阴性乳腺癌移植瘤模型。待肿瘤体积增长至100 mm3时采用随机数字表法将其分为对照组(5只)、程序性死亡受体配体1抑制剂(a PD-L1)组(6只)、放疗(RT)+a PD-L1组(6只)、Gem+a PD-L1组(6只)和三联组(6只)。除对照组外,其余四组在实验第6、8、10天于瘤内注射药物(Gem5 mg/kg,a PD-L13 mg/kg),每次注射药物24 h后,对RT+a PD-L1组、三联组进行RT(2 Gy)。实验第30天处死动物,称量各组瘤重,并对主要器官进行苏木精-伊红染色。采用流式细胞术检测各组外周血及肿瘤中浸润的CD3+CD8+T细胞绝对百分比。酶联免疫吸附试验检测各组血清和瘤内γ干扰素(IFN-γ)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的表达。免疫组织化学染色检测各组瘤中Ki-67、微血管密度(MVD)-CD31和γH2AX的表达,TUNEL检测评价细胞凋亡情况。Western blot检测各组瘤中血管内皮生长因子(VEGF)和低氧诱导因子-1α(HIF-1α)的表达。结果实验过程中各组体重比较,差异无统计学意义(P>0.05)。实验结束时,RT+a PD-L1组、三联组瘤重均低于a PD-L1组,三联组低于RT+a PD-L1组(P<0.05)。苏木精-伊红染色染色显示各组心脏、肝脏、脾脏、肾脏没有明显损伤。a PD-L1组外周血CD3+CD8+T细胞绝对百分比、TNF-α、IL-6高于对照组;RT+a PD-L1组外周血IL-6高于a PD-L1组,三联组外周血CD3+CD8+T细胞绝对百分比、IFN-γ、IL-6高于a PD-L1组;三联组外周血CD3+CD8+T细胞绝对百分比高于RT+a PD-L1组、Gem+a PD-L1组,IL-6高于Gem+a PD-L1组(P<0.05)。a PD-L1组肿瘤组织中CD3+CD8+T细胞绝对百分比、IFN-γ、TNF-α、IL-6高于对照组;RT+a PD-L1组、Gem+a PD-L1组、三联组肿瘤组织中CD3+CD8+T细胞绝对百分比高于a PD-L1组,三联组TNF-α、IL-6高于a PD-L1组;三联组肿瘤组织中CD3+CD8+T细胞绝对百分比、IL-6高于RT+a PD-L1组、Gem+a PD-L1组,IFN-γ高于RT+a PD-L1组(P<0.05)。免疫组织化学染色和TUNEL检测显示三联组肿瘤组织中Ki-67的表达减少,凋亡的细胞增多。三联组MVD-CD31低于a PD-L1组,γH2AX高于a PD-L1组、Gem+a PD-L1组(P<0.05)。a PD-L1组VEGF低于对照组,RT+a PD-L1组、Gem+a PD-L1组、三联组VEGF低于a PD-L1组,三联组HIF1α低于a PD-L1组和RT+a PD-L1组(P<0.05)。结论在小鼠三阴性乳腺癌移植瘤模型中应用放疗、Gem联合免疫检查点抑制剂的三重疗法可以延缓肿瘤生长,提高外周血和肿瘤中CD3+CD8+T细胞绝对百分比,促进血清和肿瘤中炎症因子的释放,还可以改善瘤内缺氧状况,抑制肿瘤微血管生长。 展开更多
关键词 三阴性乳腺癌 三重疗法 免疫应答 肿瘤微环境
下载PDF
贾立群教授基于“以通为补”理论外治肿瘤并发症经验 被引量:3
11
作者 文艳萍 杨闪闪 +2 位作者 娄彦妮 罗静瑶 贾立群 《海南医学院学报》 CAS 2021年第16期1268-1271,共4页
中医外治法源远流长,具有简、便、廉、验等特点,在恶性肿瘤并发症的治疗中亦发挥着重要作用。“以通为补”学术思想自古有之,至今对于指导临床治疗仍有重要意义。贾立群教授基于“以通为补”理论,以通络散外治化疗致周围神经病变,温通... 中医外治法源远流长,具有简、便、廉、验等特点,在恶性肿瘤并发症的治疗中亦发挥着重要作用。“以通为补”学术思想自古有之,至今对于指导临床治疗仍有重要意义。贾立群教授基于“以通为补”理论,以通络散外治化疗致周围神经病变,温通穴位贴外治癌性疼痛、化疗后消化道反应,均取得较好临床疗效。并附验案一则加以佐证。 展开更多
关键词 以通为补 恶性肿瘤 并发症 贾立群 中医外治
下载PDF
TNFα and reactive oxygen species in necrotic cell death 被引量:13
12
作者 Michael J Morgan You-Sun Kim Zheng-gang Liu 《Cell Research》 SCIE CAS CSCD 2008年第3期343-349,共7页
关键词 Noxl TRADD RIP1 ROS JNK 细胞坏死 受体 抗氧作用
下载PDF
HoLEP does not affect the overall sexual function of BPH patients: a prospective study 被引量:11
13
作者 Sung Hart Kim Hyung-Kook Yang +2 位作者 Hahn-Ey Lee Jae-Seung Paick Seung-June Oh 《Asian Journal of Andrology》 SCIE CAS CSCD 2014年第6期873-877,共5页
We aimed to prospectively evaluate the influence of holmium laser enucleation of the prostate (HoLEP) on the overall postoperative sexual function of benign prostatic hyperplasia (BPH) patients with lower urinary ... We aimed to prospectively evaluate the influence of holmium laser enucleation of the prostate (HoLEP) on the overall postoperative sexual function of benign prostatic hyperplasia (BPH) patients with lower urinary tract symptoms (LUTS) and to explore the relationship between sexual function and LUTS. From January 2010 to December 2011, sixty sexually active consecutive patients with BPH who underwent HoLEP were prospectively enrolled in the study. All patients filled out the Male Sexual Health Questionnaire (MSHQ) for evaluation of their overall sexual function and the International Prostatic Symptom Score (IPSS) for pre- and post-operative 6 months evaluation of their voiding symptoms. The LUTS and sexual function changes were statistically analyzed. The preoperative and 6 months postoperative status of the patients was compared using uroflowmetry and IPSS questionnaires. The analysis revealed significant improvements following HoLEP. Among the sub-domains of the MSHQ, postoperative sexual function, including erection, ejaculation, sexual satisfaction, anxiety or sexual desire, did not significantly change after HoLEP (P 〉 0.05), whereas satisfaction scores decreased slightly due to retrograde ejaculation in 38 patients (63.3%). Sexual satisfaction improved significantly and was correlated with the improvements of all LUTS and the quality-of-life (QoL) domains in IPSS after surgery (QoL; relative risk [RR]: -0.293; total symptoms, RR: -0.411; P 〈 0.05). The nocturia score was associated with the erectile function score (odds ratio 0.318, P = 0.029). The change in ejaculatory scores did not show significant association with IPSS scores. HoLEP did not influence overall sexual function, including erectile function. In addition, sexual satisfaction improved in proportion with the improvement of LUTS. 展开更多
关键词 benign prostatic hyperplasia EJACULATION erectile dysfunction LASERS prostatectomy sex disorders
下载PDF
“组合拳式”肝癌精准治疗新策略
14
作者 覃文新·研究组 覃文新 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2019年第11期1223-1225,共3页
上海交通大学医学院附属仁济医院上海市肿瘤研究所覃文新研究组与荷兰癌症研究所RenéBernards研究组合作,通过CRISPR-Cas9基因编辑敲除技术结合高通量化合物筛选,提出了利用肿瘤细胞突变来特异诱导并清除肝癌细胞而对正常细胞无影... 上海交通大学医学院附属仁济医院上海市肿瘤研究所覃文新研究组与荷兰癌症研究所RenéBernards研究组合作,通过CRISPR-Cas9基因编辑敲除技术结合高通量化合物筛选,提出了利用肿瘤细胞突变来特异诱导并清除肝癌细胞而对正常细胞无影响的“组合拳式或分步式(One-two punch)”肝癌精准治疗新策略。该研究成果以“Inducing and exploiting vulnerabilities for the treatment of liver cancer”为题于2019年10月在线发表于国际学术期刊Nature。 展开更多
关键词 癌症研究所 仁济医院 国际学术期刊 细胞突变 基因编辑 肝癌细胞 分步式
下载PDF
个性化护理在防治放化疗致皮炎、口腔黏膜炎中的应用 被引量:2
15
作者 刘金玮 《黑龙江医学》 2019年第2期191-192,共2页
目的探究个性化护理干预的应用对于防治放化疗致放射性皮炎、口腔黏膜炎的效果。方法选取天津北辰医院2016年1月—2018年2月期间收治的行放化疗的鼻咽癌患者138例,根据护理方法分为对照组和观察组,每组各69例。对照组患者行常规护理干... 目的探究个性化护理干预的应用对于防治放化疗致放射性皮炎、口腔黏膜炎的效果。方法选取天津北辰医院2016年1月—2018年2月期间收治的行放化疗的鼻咽癌患者138例,根据护理方法分为对照组和观察组,每组各69例。对照组患者行常规护理干预措施,观察组患者在对照组基础上行个性化护理干预措施,对比两组患者的放射性皮炎、口腔黏膜炎发生率。结果观察组患者放射性皮炎发生率、口腔黏膜炎发生率、护理满意度分别为5.80%、7.25%、95.65%,对照组患者则分别为17.39%、20.29%、85.51%,组间对比差异有统计学意义(P<0.05)。结论个性化护理干预措施的实施重视放射性皮炎、口腔黏膜炎的预防性护理,调动患者的主观能动性,鼓励患者主动做好自我护理,预防并发症,提高生活质量。 展开更多
关键词 个性化护理干预 放化疗 鼻咽癌 口腔黏膜炎 放射性皮炎
下载PDF
Professor Jia Li-qun’s experience in external treatment of tumor complications based on the theory of“use communication as a complement”
16
作者 Yan-Ping Wen Shan-Shan Yang +2 位作者 Yan-Ni Lou Jing-Yao Luo Li-Qun Jia 《Journal of Hainan Medical University》 2021年第16期60-63,共4页
The external treatment of Traditional Chinese Medicine has a long history of external treatment,with the characteristics of simplicity,convenience,cheapness,and effectiveness.It also plays an important role in the tre... The external treatment of Traditional Chinese Medicine has a long history of external treatment,with the characteristics of simplicity,convenience,cheapness,and effectiveness.It also plays an important role in the treatment of malignant tumor complications.The academic idea of“Use communication as a complement”has existed since ancient times,and it still has great significance in guiding clinical treatment.Based on the theory of“Use communication as a complement”,Professor JIA Liqun used Tongluo powder to treat chemotherapy-induced peripheral neuropathy,Wentong acupoint sticking for external treatment of cancer pain,and digestive tract reaction after chemotherapy,and achieved good clinical effects.An inspection case is attached to prove it. 展开更多
关键词 Use communication as a complement Malignant tumor Complication Jia Li-qun External treatment of Traditional Chinese Medicine
下载PDF
Cell signaling review series
17
作者 Arming Lin Zheng-gang Liu 《Cell Research》 SCIE CAS CSCD 2008年第3期327-327,共1页
关键词 细胞信号 细胞研究 细胞核 实验研究
下载PDF
hsa_circ_0005692吸附miR-625-5p调节CXXC4的表达而抑制胃癌的转移
18
作者 张力 包和婧 +2 位作者 邓天伟 张寒 李刚 《中国比较医学杂志》 CAS 北大核心 2021年第2期58-66,共9页
目的探讨hsa吸附miR-625-5p调节CXXC4的表达而抑制胃癌的转移及其作用机制。方法培养胃黏膜上皮细胞GES-1和人胃癌细胞系BGC-803、SNU-1、NCI-N87、HS-746T,qRT-PCR检测hsa_circ_0005692、miR-625-5p和CXXC4 mRNA的表达;双荧光素酶实验... 目的探讨hsa吸附miR-625-5p调节CXXC4的表达而抑制胃癌的转移及其作用机制。方法培养胃黏膜上皮细胞GES-1和人胃癌细胞系BGC-803、SNU-1、NCI-N87、HS-746T,qRT-PCR检测hsa_circ_0005692、miR-625-5p和CXXC4 mRNA的表达;双荧光素酶实验验证hsa_circ_0005692和miR-625-5p结合,miR-625-5p靶向调控CXXC4;RIP验证hsa_circ_0005692和AGO2结合;RNA pull down结果证明hsa_circ_0005692和miR-625-5p结合;MTT检测细胞的增殖情况;Transwell实验检测细胞迁移侵袭能力;细胞流式术检测细胞凋亡率;Western blot检测CXXC4和迁移侵袭相关因子N-cadherin和MMP-9蛋白的表达。结果在胃癌细胞中,hsa_circ_0005692和CXXC4呈低表达,而miR-625-5p呈高表达。双荧光素酶实验验证miR-625-5p能与hsa_circ_0005692和CXXC4结合,RIP实验验证AGO2蛋白与hsa_circ_0005692结合,RNA pull down实验证明hsa_circ_0005692与miR-625-5p特异性结合。过表达hsa_circ_0005692或沉默miR-625-5p可抑制胃癌细胞的增殖、迁移和侵袭能力,并促进其凋亡,迁移侵袭相关因子N-cadherin和MMP9表达下降,而过表达miR-625-5p或沉默CXXC4可逆转hsa_circ_0005692过表达对胃癌细胞生物学活性的抑制作用。结论hsa_circ_0005692可能通过吸附miR-625-5p,从而上调CXXC4基因,进而抑制胃癌细胞增殖、迁移和侵袭,并促进其凋亡。 展开更多
关键词 hsa_circ_0005692 miR-625-5p CXXC4 胃癌 吸附 转移
下载PDF
Combination of anti-PD-L1 antibody with peptide MEL-dKLA targeting M2 tumor-associated macrophages suppresses breast cancer metastasis
19
作者 Chanju Lee Hyunji Lee +9 位作者 Hayoon Cho Soyoung Kim Ilseob Choi Young-Sik Hwang Hyunju Jeong Hogi Jang Sehyun Pak Deok-Sang Hwang Ik-Hwan Han Hyunsu Bae 《Cancer Communications》 SCIE 2022年第4期345-349,共5页
Dear editors,Breast cancer is a leading cause of cancer-related deaths worldwide and is the most common cancer among women[1].The cause of death in patients with breast cancer is not the primary tumor itself but mainl... Dear editors,Breast cancer is a leading cause of cancer-related deaths worldwide and is the most common cancer among women[1].The cause of death in patients with breast cancer is not the primary tumor itself but mainly metastasis.The most common sites of breast cancer metastasis include the bones,lungs,brain,lymph nodes,and liver.Importantly,lung metastasis has been a particular concern as it results in high patient morbidity and mortality rates[2]. 展开更多
关键词 METASTASIS BREAST MORTALITY
原文传递
2020年全球不同国家或地区人群一生患癌风险评估 被引量:3
20
作者 郑荣寿 王少明 +6 位作者 张思维 曾红梅 陈茹 孙可欣 李荔 Freddie Bray 魏文强 《Science Bulletin》 SCIE EI CAS CSCD 2023年第21期2620-2628,M0006,共10页
一生患癌风险是衡量癌症负担的重要指标.但关于不同人群的患癌风险评估的研究目前仍然较少.本研究从GLOBOCAN获得了全球185个国家或地区2020年的癌症数据,从联合国经济和社会事务部人口司获得全因死亡率和人口数据,采用多原发调整法估... 一生患癌风险是衡量癌症负担的重要指标.但关于不同人群的患癌风险评估的研究目前仍然较少.本研究从GLOBOCAN获得了全球185个国家或地区2020年的癌症数据,从联合国经济和社会事务部人口司获得全因死亡率和人口数据,采用多原发调整法估计人群一生患癌风险.结果显示,全球来看,人群一生患癌风险约为25.10%(95%CI:25.08%~25.11%);男性26.27%(95%CI:26.24%~26.30%),女性23.96%(95%CI:23.93%~23.98%).其中,在人类发展指数(HDI)极高、较高、中等和较低的国家或地区中,一生患癌风险分别为38.48%、25.38%、11.36%和10.34%.男性和女性一生患癌风险最高的分别是前列腺癌症(4.65%)和乳腺癌症(5.90%).余生继续患癌风险随着年龄的增长逐渐降低,但是,70岁未患癌的人群仍然还有12.61%的患癌风险.纵观一生,大约有1/4的人会罹患癌症,男性和女性患癌风险总体上无统计学差异.一生患癌风险的指标可以为癌症预防和卫生系统规划提供重要信息和参考. 展开更多
关键词 癌症预防 卫生系统 全因死亡率 前列腺癌症 患癌风险 社会事务部 男性和女性 多原发
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部